Bausch Health’s (NYSE:BHC) Bausch + Lomb and Clearside Biomedical (Nasdaq:CLSD) launched their Xipere product in the U.S. today. Clearside Biomedical designed the Xipere triamcinolone acetonide suprachoroidal injectable suspension therapy with a proposed indication for treating macular edema associated with uveitis, a form of eye inflammation. Xipere works with Clearside’s proprietary SCS Microinjector to deliver the therapy to […]
Optical/Ophthalmic
Staar Surgical wins FDA approval for Evo Visian implantable Collamer lens
Staar Surgical (Nasdaq:STAA) announced today that it received FDA approval for its Evo/Evo+ Visian implantable Collamer lens. Lake Forest, California-based Staar Surgical designed the Evo biocompatible implantable lens for the correction of myopia and myopia with astigmatism. More than 1 million Evo lenses have been implanted by doctors outside the U.S., according to a news […]
J&J is bringing the world’s first drug-eluting contact lens to market
J&J has a potential alternative to eye drops with its drug-eluting Acuvue Theravision contact lens. As far back as the early 1960s, researchers toyed with the idea of delivering medication through contact lenses. Johnson & Johnson Vision (NYSE:JNJ) Director of Clinica Science Dr. Brian Pall told Drug Delivery Business News that patents back then disclosed how a soft […]
Johnson & Johnson Medical Devices drops ‘medical devices’ in rebranding
Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology. New Brunswick, New Jersey-based Johnson & Johnson (NYSE: JNJ) noted the coming change in its 2022 annual report published last month, saying the switch would take effect in the company’s first fiscal quarter. That preview […]
This CEO is swallowing his own devices to fund his swimming PillBot
As he prepared to swallow his robot for the first time, Torrey Smith’s doctors warned that the battery was his greatest threat. If the capsule came apart and the battery burned the tissue lining his stomach, it would only be the beginning of a very bad experience. “I was just hoping that we would get […]
How Minnetronix helped Oculogica launch its new EyeBOX concussion diagnostic device
Less than three months after Oculogica won FDA clearance for its portable concussion diagnostic device, contract manufacturer Minnetronix is about to ship the first units to customers. “We are aspiring to be a vital sign for brain health,” Oculogica CEO Rosina Samadani said in an interview. Diagnosing a concussion used to require asking a patient […]
Alcon launches Clareon intraocular lens in U.S.
Alcon (SIX/NYSE:ALC) announced today that it launched the Clareon family of intraocular lenses (IOLs) in the U.S. Geneva, Switzerland-based Alcon designed the Clareon family of lenses with a glistening-free IOL material with the lowest levels of haze and subsurface nanoglistenings (SSNGs) compared to leading competitors’ IOLs, according to a news release. The company describes Clareon […]
FDA approves Johnson & Johnson Vision’s drug-eluting contact lens
Johnson & Johnson Vision announced today that it received FDA approval for its Acuvue Theravision with Ketotifen. The eye health business arm of Johnson & Johnson (NYSE:JNJ) designed Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen) to provide a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 […]
Ocular Therapeutix misses on Q4 projections
Ocular Therapeutix (NSDQ:OCUL) shares ticked up today despite fourth-quarter results that missed the consensus revenue forecast. The Bedford, Massachusetts-based company posted losses of $3.9 million, or 5¢ per share, on sales of $12.3 million for the three months ended Dec. 31, 2021, for a massive bottom-line gain moving from $85.6 million in losses this time […]
Staar Surgical grows sales 28% in Q4 results
Staar Surgical (NSDQ:STAA) posted fourth-quarter results this week that beat the earnings consensus on Wall Street and missed revenue estimates. The Lake Forest, California-based company reported profits of $4.9 million, or 10¢ per share, on sales of $59 million for the three months ended Dec. 31, 2020, for a bottom-line gain of 47.9% on sales growth […]
Glaukos rises on Street-beating Q4
Glaukos (NYSE:GKOS) shares ticked up today on fourth-quarter results that beat the consensus forecast. The San Clemente, California-based eye disease treatment developer posted losses of $21.9 million, or losses per share of 47¢, on sales of $73.2 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on […]